Antibodies Stocks List

Antibodies Stocks Recent News

Date Stock Title
May 8 TECH AI Adoption In Workplace: Employees Concealing Use Of AI Tools For Fear Of Job Replacement, Microsoft-Led Study Reveals
May 8 TECH Reddit's Enhanced Advertising Tools Drive 'Sizable Upside': JPMorgan
May 8 TECH Former Google CEO Eric Schmidt Says US Is Ahead Of China In AI By '2-3 Years:' 'We Should Be Very Proud To Be Here'
May 8 STRO Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
May 8 REGN Regeneron gene therapy improves hearing in child deafness
May 8 HALO Q1 2024 Halozyme Therapeutics Inc Earnings Call
May 8 TECH BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
May 8 CMMB Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
May 8 TECH 200 Jobs In Jeopardy As Microsoft Halts Operations At Nigeria Engineering Center Amid Economic Struggles
May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
May 8 TECH TikTok Admits Xi Jinping's CCP Won't Let Its Algorithm Be Sold After Biden Gives 9 Months To Divest Or Be Banned: 'Chinese Government Has Made It Clear'
May 8 TECH Mickey Mouse Loses Magic In India As Disney+ Hotstar Suffers Major Subscriber Drop
May 8 TECH YouTube Tech Reviewer MKBHD Scoffs At Apple's New iPad Lineup: 'It's A Spec Bump'
May 8 TECH Apple's iPad Sales To Get A 'Nice Boost' This Year, But Expect A Decline In 2025, Says Gene Munster
May 8 TECH AI Boom To Drive Billions In Data Center Investments In APAC: Report
May 8 HALO Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
May 8 TECH Intel, Qualcomm Export Licenses Revoked By US, Tech Giants Won't Be Able To Sell Chips To Huawei: Report
May 8 TECH Disney CEO Bob Iger Remains Tight-Lipped On Successor, But Assures 'Smooth Transition'
May 8 TECH Bob Iger Says This Streaming Platform Is The Gold Standard, Praises Rival For Cracking Down On Password Sharing: 'We're Heartened By The Results That Netflix Has Delivered'
May 8 TECH Elon Musk Isn't Sure Apple's Showed Its Entire $30B R&D Prowess With New iPads: 'Maybe They Have Some Secret Products…'
Antibodies

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region. Each tip of the "Y" of an antibody contains a paratope (analogous to a lock) that is specific for one particular epitope (similarly, analogous to a key) on an antigen, allowing these two structures to bind together with precision. Using this binding mechanism, an antibody can tag a microbe or an infected cell for attack by other parts of the immune system, or can neutralize its target directly (for example, by inhibiting a part of a microbe that is essential for its invasion and survival). Depending on the antigen, the binding may impede the biological process causing the disease or may activate macrophages to destroy the foreign substance. The ability of an antibody to communicate with the other components of the immune system is mediated via its Fc region (located at the base of the "Y"), which contains a conserved glycosylation site involved in these interactions. The production of antibodies is the main function of the humoral immune system.Antibodies are secreted by B cells of the adaptive immune system, mostly by differentiated B cells called plasma cells. Antibodies can occur in two physical forms, a soluble form that is secreted from the cell to be free in the blood plasma, and a membrane-bound form that is attached to the surface of a B cell and is referred to as the B-cell receptor (BCR). The BCR is found only on the surface of B cells and facilitates the activation of these cells and their subsequent differentiation into either antibody factories called plasma cells or memory B cells that will survive in the body and remember that same antigen so the B cells can respond faster upon future exposure. In most cases, interaction of the B cell with a T helper cell is necessary to produce full activation of the B cell and, therefore, antibody generation following antigen binding. Soluble antibodies are released into the blood and tissue fluids, as well as many secretions to continue to survey for invading microorganisms.
Antibodies are glycoproteins belonging to the immunoglobulin superfamily. They constitute most of the gamma globulin fraction of the blood proteins. They are typically made of basic structural units—each with two large heavy chains and two small light chains. There are several different types of antibody heavy chains that define the five different types of crystallisable fragments (Fc) that may be attached to the antigen-binding fragments. The five different types of Fc regions allow antibodies to be grouped into five isotypes. Each Fc region of a particular antibody isotype is able to bind to its specific Fc Receptor (except for IgD, which is essentially the BCR), thus allowing the antigen-antibody complex to mediate different roles depending on which FcR it binds. The ability of an antibody to bind to its corresponding FcR is further modulated by the structure of the glycan(s) present at conserved sites within its Fc region. The ability of antibodies to bind to FcRs helps to direct the appropriate immune response for each different type of foreign object they encounter. For example, IgE is responsible for an allergic response consisting of mast cell degranulation and histamine release. IgE's Fab paratope binds to allergic antigen, for example house dust mite particles, while its Fc region binds to Fc receptor ε. The allergen-IgE-FcRε interaction mediates allergic signal transduction to induce conditions such as asthma.Though the general structure of all antibodies is very similar, a small region at the tip of the protein is extremely variable, allowing millions of antibodies with slightly different tip structures, or antigen-binding sites, to exist. This region is known as the hypervariable region. Each of these variants can bind to a different antigen. This enormous diversity of antibody paratopes on the antigen-binding fragments allows the immune system to recognize an equally wide variety of antigens. The large and diverse population of antibody paratope is generated by random recombination events of a set of gene segments that encode different antigen-binding sites (or paratopes), followed by random mutations in this area of the antibody gene, which create further diversity. This recombinational process that produces clonal antibody paratope diversity is called V(D)J or VJ recombination. Basically, the antibody paratope is polygenic, made up of three genes, V, D, and J. Each paratope locus is also polymorphic, such that during antibody production, one allele of V, one of D, and one of J is chosen. These gene segments are then joined together using random genetic recombination to produce the paratope. The regions where the genes are randomly recombined together is the hyper variable region used to recognise different antigens on a clonal basis.
Antibody genes also re-organize in a process called class switching that changes the one type of heavy chain Fc fragment to another, creating a different isotype of the antibody that retains the antigen-specific variable region. This allows a single antibody to be used by different types of Fc receptors, expressed on different parts of the immune system.

Browse All Tags